Filing Flows › Crispr Therapeutics AG (CRSP) › Grant revenue
Crispr Therapeutics AG (CRSP) Grant revenue by quarter
Crispr Therapeutics AG's Grant revenue was $346K in Q3 2026 (third quarter 2026), +91% from Q2 2026. Over the last 3 quarters it ranged from $181K (Q2 2026) to $458K (Q1 2026).
| Quarter | Grant revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $346K | +91% | — |
| Q2 2026 | $181K | -60% | — |
| Q1 2026 | $458K | — | — |
Q3 2026 at a glance
Crispr Therapeutics AG, Q3 2026: revenue $12.7M (14× year over year), net loss $111M, operating cash flow −$89.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Crispr Therapeutics AG's Grant revenue?
Crispr Therapeutics AG's Grant revenue was $346K in Q3 2026 (third quarter 2026), +91% from Q2 2026.
How has Crispr Therapeutics AG's Grant revenue changed?
Over the last 3 quarters it ranged from $181K (Q2 2026) to $458K (Q1 2026).
Q3 2026 results → · How Crispr Therapeutics AG makes money →